Zevra Therapeutics (ZVRA) Institutional Ownership $8.48 +0.04 (+0.47%) (As of 12/17/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Zevra Therapeutics (NASDAQ:ZVRA)CurrentInstitutional OwnershipPercentage35.03%Number ofInstitutional Buyers(last 12 months)37TotalInstitutional Inflows(last 12 months)$34.25MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$1.98M Get ZVRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Zevra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ZVRA Institutional Buying and Selling by Quarter Ad Crypto 101 MediaDeFi Coin on Verge of Breakout![FREE BOOK] Can You Make a Fortune in Crypto with $50? Get started now before the market takes off! Click here to request your free copy NOW! Zevra Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/25/2024 Sanctuary Advisors LLC27,924$194K0.0%-73.4%0.052% 11/20/2024 Virtu Financial LLC18,367$127K0.0%N/A0.034% 11/19/2024 Barclays PLC57,599$399K0.0%+292.6%0.108% 11/16/2024 Geode Capital Management LLC1,043,864$7.25M0.0%+14.2%1.984% 11/15/2024 Barclays PLC57,599$399K0.0%+292.6%0.109% 11/15/2024 XTX Topco Ltd13,551$94K0.0%N/A0.026% Get the Latest News and Ratings for ZVRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Zevra Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024 State Street Corp772,825$5.36M0.0%+7.4%1.469% 11/14/2024 Vestal Point Capital LP525,000$3.64M0.3%N/A0.998% 11/14/2024 Stonepine Capital Management LLC700,000$4.86M3.1%N/A1.330% 11/14/2024 MetLife Investment Management LLC22,866$159K0.0%+8.1%0.043% 11/13/2024 Rubric Capital Management LP20,000$139K0.0%N/A0.038% 11/13/2024 Propel Bio Management LLC179,874$1.25M0.7%N/A0.342% 11/13/2024 Quantbot Technologies LP20,243$140K0.0%N/A0.038% 11/13/2024 FMR LLC2,313,202$16.05M0.0%+282,687.5%4.396% 11/12/2024 Valence8 US LP21,596$150K0.1%N/A0.041% 11/12/2024 Charles Schwab Investment Management Inc.121,356$842K0.0%+10.0%0.231% 11/9/2024 Intech Investment Management LLC13,748$95K0.0%N/A0.026% 11/6/2024 Simplify Asset Management Inc.120,000$833K0.0%N/A0.228% 10/29/2024 Janney Montgomery Scott LLC305,069$2.12M0.0%-29.5%0.729% 10/24/2024 Hunter Associates Investment Management LLC13,260$92K0.0%N/A0.032% 10/22/2024 International Assets Investment Management LLC6,940$48K0.0%+594.0%0.017% 10/18/2024IFG Advisors LLC26,400$183K0.0%+41.2%0.063% 10/10/2024 City State Bank16,224$113K0.0%+14.1%0.039% 10/3/2024 SG Americas Securities LLC15,198$105K0.0%N/A0.036% 9/5/2024 Sanctuary Advisors LLC104,924$474K0.0%N/A0.199% 8/20/2024 Nantahala Capital Management LLC2,419,435$11.86M0.7%-1.4%5.781% 8/15/2024 The Manufacturers Life Insurance Company18,573$91K0.0%+15.2%0.044% 8/9/2024 Renaissance Technologies LLC112,800$553K0.0%-27.4%0.270% 8/9/2024 Retirement Planning Co of New England Inc.458,300$2.25M1.2%+6.5%1.095% 8/9/2024 Mystic Asset Management Inc.297,947$1.46M0.6%+11.9%0.712% 8/1/2024 Rhumbline Advisers56,874$279K0.0%+17.9%0.136% 7/26/2024 Bank of New York Mellon Corp220,499$1.08M0.0%+10.7%0.527% 5/16/2024 Jacobs Levy Equity Management Inc.34,707$201K0.0%+102.4%0.083% 5/15/2024 Price T Rowe Associates Inc. MD11,011$64K0.0%N/A0.026% 5/10/2024 Vanguard Group Inc.1,704,006$9.88M0.0%+3.6%3.924% 5/7/2024 Retirement Planning Co of New England Inc.430,193$2.50M1.4%+11.0%0.991% 5/7/2024 Mystic Asset Management Inc.266,297$1.55M0.6%+15.4%0.613% 5/7/2024 SG Americas Securities LLC12,680$74K0.0%-39.6%0.029% 5/1/2024 Janney Montgomery Scott LLC660,169$3.83M0.0%-3.4%1.520% 4/25/2024IFG Advisors LLC18,700$108K0.0%+45.0%0.043% Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 2/26/2024 Virtu Financial LLC26,966$177K0.0%N/A0.074% 2/13/2024 Tower Research Capital LLC TRC9,673$63K0.0%+134.3%0.027% 2/13/2024 Armistice Capital LLC268,000$1.76M0.0%N/A0.740% 2/12/2024Focus Financial Network Inc. ADV21,500$141K0.0%N/A0.059% 2/8/2024 Janney Montgomery Scott LLC683,431$4.48M0.0%+1.3%1.887% 2/7/2024 Jump Financial LLC33,200$217K0.0%N/A0.092% 2/2/2024 Kovack Advisors Inc.141,401$926K0.1%+13.9%0.390% 1/30/2024 Strs Ohio19,400$127K0.0%+151.9%0.054% 1/24/2024 International Assets Investment Management LLC6,550$43K0.0%+555.0%0.018% 1/12/2024 SG Americas Securities LLC20,999$138K0.0%+41.7%0.058% 12/6/2023 VisionPoint Advisory Group LLC6,860$33K0.0%N/A0.019% 11/15/2023 Laurion Capital Management LP31,200$150K0.0%N/A0.086% 11/13/2023 Retirement Planning Co of New England Inc.347,402$1.67M0.9%N/A0.959% 11/13/2023 Mystic Asset Management Inc.203,283$980K0.6%N/A0.561% 11/8/2023 Janney Montgomery Scott LLC674,369$3.25M0.0%N/A1.988% 11/7/2023 Kingsview Wealth Management LLC12,120$58K0.0%N/A0.036% 10/31/2023IFG Advisors LLC12,900$62K0.0%N/A0.038% 10/26/2023 Mirae Asset Global Investments Co. Ltd.19,072$92K0.0%N/A0.056% 10/26/2023 Strs Ohio7,700$37K0.0%N/A0.023% 10/24/2023 Bank of New York Mellon Corp202,773$977K0.0%N/A0.598% 10/24/2023Stratos Wealth Partners LTD.70,200$338K0.0%N/A0.207% 10/24/2023Raymond James Financial Services Advisors Inc.26,228$126K0.0%N/A0.077% 10/23/2023Commonwealth Equity Services LLC10,858$52K0.0%N/A0.032% 10/18/2023 Measured Wealth Private Client Group LLC10,000$48K0.0%N/A0.029% 10/16/2023 City State Bank14,224$69K0.0%N/A0.042% 10/13/2023 SG Americas Securities LLC14,824$71K0.0%N/A0.044% (Data available from 1/1/2016 forward) ZVRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ZVRA shares? During the previous two years, 47 institutional investors and hedge funds held shares of Zevra Therapeutics. The most heavily invested institutionals were FMR LLC ($16.05M), Nantahala Capital Management LLC ($11.86M), Vanguard Group Inc. ($9.88M), Geode Capital Management LLC ($7.25M), State Street Corp ($5.36M), Stonepine Capital Management LLC ($4.86M), and Vestal Point Capital LP ($3.64M).Learn more on ZVRA's institutional investors. What percentage of Zevra Therapeutics stock is owned by institutional investors? 35.03% of Zevra Therapeutics stock is owned by institutional investors. Learn more on ZVRA's institutional investor holdings. Which institutional investors have been buying Zevra Therapeutics stock? Of the 45 institutional investors that purchased Zevra Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.31M), Stonepine Capital Management LLC ($700K), Janney Montgomery Scott LLC ($683.43K), Vestal Point Capital LP ($525K), Retirement Planning Co of New England Inc. ($418.28K), Mystic Asset Management Inc. ($270.45K), and Armistice Capital LLC ($268K). How much institutional buying is happening at Zevra Therapeutics? Institutional investors have bought a total of 6,707,534 shares in the last 24 months. This purchase volume represents approximately $42.27M in transactions. Which Zevra Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Zevra Therapeutics stock in the last 24 months: Janney Montgomery Scott LLC ($151.02K), Sanctuary Advisors LLC ($77K), Renaissance Technologies LLC ($42.60K), Nantahala Capital Management LLC ($33.97K), and SG Americas Securities LLC ($8.32K). How much institutional selling is happening at Zevra Therapeutics? Institutional investors have sold a total of 312,906 shares in the last 24 months. This volume of shares sold represents approximately $1.98M in transactions. Related Companies Galapagos Major Shareholders Xencor Major Shareholders Evotec Major Shareholders Arcutis Biotherapeutics Major Shareholders Arcus Biosciences Major Shareholders Nurix Therapeutics Major Shareholders Kiniksa Pharmaceuticals Major Shareholders Immunocore Major Shareholders Ocular Therapeutix Major Shareholders Mesoblast Major Shareholders This page (NASDAQ:ZVRA) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zevra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zevra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
